Home › Funds › Mercuria Capital Strategies, LLC › DMII

Mercuria Capital Strategies, LLC position in DMII

DRUGS MADE IN AMER ACQ II CO · Financials

Mercuria Capital Strategies, LLC reported holding 750,000 shares of DMII (DRUGS MADE IN AMER ACQ II CO) in its Q3 2026 13F filing — a position valued at US$7.6M, representing 8.31% of its reported portfolio and ranking #5 among its reported holdings. Mercuria Capital Strategies, LLC has disclosed DMII holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

Latest position (Q3 2026)750.00K sh
Reported value held$7.63M
Portfolio Weight8.31%
First reportedQ1 2026
Last changeHold
Updated2026-11-10

Last updated: 2026-11-10 · Source: SEC EDGAR Form 13F-HR

How Mercuria Capital Strategies, LLC's DMII position evolved

Mercuria Capital Strategies, LLC first disclosed a stake in DMII in Q1 2026 at 750,000 shares (US$7.5M). The position peaked in Q3 2026 at 750,000 shares, worth US$7.6M. Across 3 filings, Mercuria Capital Strategies, LLC held the position steady without any share-count change. The most recent filing (Q3 2026) shows 750,000 shares valued at US$7.6M.

Quarter by quarter

QuarterSharesValueChange
Q1 2026 750.00K $7.48M New
Q2 2026 750.00K $7.54M Hold
Q3 2026 750.00K $7.63M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About DMII and 13F data

DMII (DRUGS MADE IN AMER ACQ II CO) is a Financials company. 70 other funds we track also report a position in DMII — the largest reported positions include Karpus Management, Inc. (US$28.0M), Magnetar Financial LLC (US$27.2M), MMCAP International Inc. SPC (US$27.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding DMII

All DMII fund holders →

FAQ

How long has Mercuria Capital Strategies, LLC held DMII?

Mercuria Capital Strategies, LLC has disclosed DMII holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

What is Mercuria Capital Strategies, LLC's current position in DMII?

As of Q3 2026, Mercuria Capital Strategies, LLC holds 750.00K shares of DMII (DRUGS MADE IN AMER ACQ II CO), valued at $7.63M, representing 8.31% of its reported portfolio and ranking #5.

Has Mercuria Capital Strategies, LLC been buying or selling DMII?

In the latest 13F filing (Q3 2026), Mercuria Capital Strategies, LLC held unchanged its position in DMII. The position peaked in Q3 2026 at 750.00K shares.

Which other funds hold DMII?

Other major institutional holders of DMII include Karpus Management, Inc., Magnetar Financial LLC, MMCAP International Inc. SPC, among 70 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.